Bolt Biotherapeutics, Inc.

Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor recep…

Biotechnology

US, Redwood City [HQ]

Summary
IR
Fin. Reports
Financials
Leadership & Strategy
Possible Catalysts

Analysts
Dividend Payments
Government Awards
Insiders
Lobbying Expenses
Segment Revenues
Shareholder Structure
Supply / Portfolio
Valuation Models [Soon]

Lobbying Analysis

Lobbying · US Senate · Influence

Here you'll find all expenses made over the past 12M of Bolt Biotherapeutics, Inc. to fulfill lobbying activities in the US.

Bolt Biotherapeutics, Inc. has no lobbying expenses in our database.

History

Download

FY	Quarter	Expense For Lobby Disclosure	LDA Reference
No data